Compare Lustrum:Carna Biosciences,Inc.:4572

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Carna Biosciences,Inc. Go to web site 4572 Medicals 東証グロース December 1, 2000 2008.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Carna Biosciences,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Carna Biosciences,Inc. Balance Sheet 2023年12月期 Carna Biosciences,Inc. Balance Sheet 2022年12月期 Carna Biosciences,Inc. Balance Sheet 2021年12月期 Carna Biosciences,Inc. Balance Sheet 2020年12月期 Carna Biosciences,Inc. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents
(Percent)
2,889down
(66.4%)down
3,379down
(79.2%)up
3,818down
(70.3%)down
4,299down
(88.9%)down
4,915
(91.4%)
Other Current AssetsHelp
(Percent)
1,302up
(29.9%)up
725down
(17.0%)down
1,501up
(27.6%)up
409up
(8.5%)up
360
(6.7%)
Tangible Fixed AssetsHelp
(Percent)
105up
(2.4%)up
100up
(2.3%)up
52down
(0.9%)down
53up
(1.1%)up
30
(0.6%)
Intangible Fixed AssetHelp
(Percent)
1down
(0.0%)down
2down
(0.0%)down
3down
(0.1%)down
4up
(0.1%)up
0
(0.0%)
Investments and OthersHelp
(Percent)
52down
(1.2%)down
60up
(1.4%)up
60down
(1.1%)down
70down
(1.5%)up
72
(1.3%)
Total AssetsHelp
(Percent)
4,350
(100%)
4,266
(100%)
5,433
(100%)
4,835
(100%)
5,377
(100%)
Total Current LiabilitiesHelp
(Percent)
416down
(9.6%)down
476down
(11.2%)down
817up
(15.0%)down
771down
(16.0%)down
1,093
(20.3%)
Total Long-term LiabilitiesHelp
(Percent)
56down
(1.3%)down
148down
(3.5%)down
300up
(5.5%)up
240down
(5.0%)down
430
(8.0%)
Shareholder's EquityHelp
(Percent)
3,878up
(89.1%)up
3,642down
(85.4%)up
4,316up
(79.4%)up
3,824down
(79.1%)up
3,854
(71.7%)
Total LiabilitiesHelp
(Percent)
4,350
(100%)
4,266
(100%)
5,433
(100%)
4,835
(100%)
5,377
(100%)

Carna Biosciences,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Carna Biosciences,Inc. Profit and Loss Account 2023年12月期 Carna Biosciences,Inc. Profit and Loss Account 2022年12月期 Carna Biosciences,Inc. Profit and Loss Account 2021年12月期 Carna Biosciences,Inc. Profit and Loss Account 2020年12月期 Carna Biosciences,Inc. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales
(Percent)
1,626
(100%)
1,387
(100%)
2,018
(100%)
1,133
(100%)
3,207
(100%)
Total Sales
(Percent)
1,626
(100%)
1,387
(100%)
2,018
(100%)
1,133
(100%)
3,207
(100%)
Cost of SalesHelp
(Percent)
175up
(10.8%)down
172up
(12.4%)up
135down
(6.7%)down
192down
(17.0%)up
208
(6.5%)
Other Costs and RevenueHelp 2,603up
(160.1%)down
2,565up
(184.9%)up
2,417up
(119.8%)down
2,052down
(181.1%)up
2,172
(67.7%)
Total CostsHelp 2,779 2,736 2,552 2,244 2,379
Net RevenueHelp 1,451up
(89.2%)up
1,215down
(87.6%)down
1,882up
(93.3%)up
941down
(83.0%)down
3,000
(93.5%)
Earnings Before TaxHelp -1,131up
(-69.6%)up
-1,323down
(-95.4%)down
-532up
(-26.4%)up
-1,102down
(-97.3%)down
913
(28.5%)
Net IncomeHelp -1,153up
(-70.9%)up
-1,350down
(-97.3%)down
-534up
(-26.5%)up
-1,111down
(-98.0%)down
828
(25.8%)
当期純利益 -1,153 -1,350 -534 -1,111 828

Carna Biosciences,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Carna Biosciences,Inc. Cash Flow Statement 2023年12月期 Carna Biosciences,Inc. Cash Flow Statement 2022年12月期 Carna Biosciences,Inc. Cash Flow Statement 2021年12月期 Carna Biosciences,Inc. Cash Flow Statement 2020年12月期 Carna Biosciences,Inc. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-1,677down
(-99.3%)down
-708up
(-84.9%)up
-1,537down
(-97.4%)down
-1,261down
(-94.1%)down
1,478
(41.0%)
Investing Cash Flow(ICF)Help
(Percent)
-11up
(-0.7%)up
-126down
(-15.1%)down
-42up
(-2.6%)up
-70down
(-5.3%)down
-41
(-1.1%)
Financing Cash FlowHelp
(Percent)
1,182up
(70.0%)up
367down
(44.0%)down
1,065up
(67.5%)up
724down
(54.0%)down
2,122
(58.9%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
17down
(1.0%)down
28down
(3.4%)up
32up
(2.0%)up
-9down
(-0.7%)down
1
(0.0%)
Net Increase and Decrease in Cash and Cash Equivalentsn -490down
(-29.0%)up
-439up
(-52.6%)down
-481up
(-30.5%)up
-616down
(-46.0%)down
3,560
(98.9%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Carna Biosciences,Inc.

Company where related level is highHelp

Cyfuse Biomedical K.K.
Carna Biosciences,Inc.
ROHTO PHARMACEUTICAL CO.,LTD.
RaQualia Pharma Inc.
SanBio Company Limited
HEALIOS K.K.
Noile-Immune Biotech Inc.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
BrightPath Biotherapeutics Co., Ltd.
Medrx Co.,Ltd.